Skip to main content
Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.745
+0.005 (0.18%)
At close: Apr 28, 2026, 4:00 PM EDT
2.730
-0.015 (-0.55%)
After-hours: Apr 28, 2026, 4:04 PM EDT

Exagen Revenue

In the year 2025, Exagen had annual revenue of $66.58M with 19.65% growth. Exagen had revenue of $16.63M in the quarter ending December 31, 2025, with 21.79% growth.

Revenue (ttm)
$66.58M
Revenue Growth
+19.65%
P/S Ratio
0.99
Revenue / Employee
$302,614
Employees
220
Market Cap
66.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202566.58M10.93M19.65%
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
FONAR 106.03M
Prenetics Global 92.39M
Biodesix 88.50M
Burning Rock Biotech 77.14M
XWELL 29.21M
Precipio 24.05M
Revenue Rankings

XGN News

More News